| Entry |
|
|---|
| Name |
Medrysone (USAN);
HMS (TN) |
|---|
| Formula |
C22H32O3
|
|---|
| Exact mass |
344.2351
|
|---|
| Mol weight |
344.4877
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Anti-inflammatory (ophthalmic), Glucocorticoid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01B ANTIINFLAMMATORY AGENTS
S01BA Corticosteroids, plain
S01BA08 Medrysone
D02289 Medrysone (USAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid
D02289 Medrysone
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
3-Ketosteroid receptor
NR3C1 (GR)
D02289 Medrysone (USAN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 25
1 C1x C 22.1242 -19.7208
2 C5x C 22.1242 -21.0885
3 C2x C 23.3087 -21.7724
4 C2y C 24.4932 -21.0885
5 C1z C 24.4932 -19.7208
6 C1x C 23.3087 -19.0369
7 C1y C 25.6778 -21.7724
8 C1x C 26.8623 -21.0885
9 C1y C 26.8623 -19.7208
10 C1y C 25.6778 -19.0369
11 C1y C 28.0468 -19.0369
12 C1z C 28.0468 -17.6691
13 C1x C 26.8623 -16.9852
14 C1y C 25.6778 -17.6691
15 C1x C 30.4159 -19.0369
16 C1x C 30.4159 -17.6691
17 C1y C 29.2314 -16.9852
18 C5a C 29.2367 -15.6175
19 C1a C 28.0512 -16.3013
20 O1a O 24.4953 -16.9863
21 C1a C 24.4950 -18.3530
22 C1a C 25.6804 -23.1402
23 O5x O 20.9397 -21.7724
24 O5a O 30.4238 -14.9381
25 C1a C 28.0547 -14.9290
BOND 28
1 1 2 1
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 9 11 1
13 11 12 1
14 12 13 1
15 13 14 1
16 10 14 1
17 11 15 1
18 15 16 1
19 16 17 1
20 12 17 1
21 17 18 1 #Up
22 12 19 1 #Up
23 14 20 1 #Up
24 5 21 1 #Up
25 7 22 1 #Down
26 2 23 2
27 18 24 2
28 18 25 1
|
|---|
